Saskia Middeldorp Selected Research

Thrombophilia

2/2022	Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?
10/2019	Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis.
4/2017	Circulating activated protein C in thrombophilia carriers.
12/2016	Inherited thrombophilia: a double-edged sword.
10/2016	Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals.
5/2015	ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
2/2015	New studies of low-molecular-weight heparin in pregnancy.
12/2014	Anticoagulation in pregnancy complications.
7/2014	Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
11/2013	Antithrombotic therapy for pregnancy loss.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saskia Middeldorp Research Topics

Disease

58	Hemorrhage 06/2022 - 05/2008
55	Venous Thromboembolism 01/2022 - 03/2002
27	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 07/2003
25	Thrombosis (Thrombus) 01/2022 - 07/2003
24	Pulmonary Embolism 04/2022 - 01/2004
21	Thrombophilia 02/2022 - 01/2004
19	Neoplasms (Cancer) 01/2022 - 05/2008
16	COVID-19 01/2022 - 11/2020
11	Pregnancy Complications 02/2022 - 08/2008
10	Thrombocytopenia (Thrombopenia) 10/2022 - 07/2017
8	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 01/2009
8	Pre-Eclampsia (Preeclampsia) 01/2020 - 07/2014
8	Habitual Abortion (Recurrent Miscarriage) 05/2015 - 01/2009
6	Thromboembolism 12/2021 - 03/2005
5	Critical Illness (Critically Ill) 01/2022 - 07/2021
5	Spontaneous Abortion (Miscarriage) 01/2019 - 01/2009
4	Atrial Fibrillation 06/2022 - 10/2014
4	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 01/2021
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 07/2014
4	Uterine Hemorrhage (Uterine Bleeding) 01/2019 - 10/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 10/2006
4	Obesity 01/2016 - 01/2005
4	Hyperhomocysteinemia 07/2008 - 10/2004
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 08/2018
3	Inflammation (Inflammations) 01/2022 - 11/2014
3	Hypersensitivity (Allergy) 03/2021 - 01/2015
3	Menorrhagia 02/2021 - 10/2015
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 01/2019
3	Myocardial Infarction 12/2020 - 09/2004
3	Overweight 01/2016 - 09/2007
3	Protein S Deficiency (Deficiency, Protein S) 01/2011 - 03/2005
2	Pulmonary Hypertension 04/2022 - 01/2019
2	Frailty 01/2022 - 10/2018
2	Stroke (Strokes) 12/2020 - 12/2020
2	Fetal Diseases (Embryopathy) 12/2020 - 09/2016
2	Abruptio Placentae (Placental Abruption) 11/2019 - 05/2015
2	Protein C Deficiency 10/2019 - 07/2003
2	Hypertension (High Blood Pressure) 01/2019 - 01/2019
2	Thrombophlebitis 12/2018 - 02/2014
2	Body Weight (Weight, Body) 10/2018 - 10/2013
2	Coronary Disease (Coronary Heart Disease) 12/2017 - 01/2011

Drug/Important Bio-Agent (IBA)

49	AnticoagulantsIBA 01/2022 - 03/2002
25	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2021 - 05/2008
23	Heparin (Liquaemin)FDA LinkGeneric 02/2022 - 05/2008
21	Vitamin K FDA Link 01/2022 - 12/2004
15	Prothrombin (Factor II)IBA 03/2021 - 07/2003
13	RivaroxabanIBA 06/2022 - 10/2015
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2021 - 01/2009
12	factor V LeidenIBA 01/2020 - 03/2002
11	Factor Xa InhibitorsIBA 01/2022 - 10/2013
10	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022 - 01/2009
9	Protein CIBA 04/2017 - 07/2008
8	edoxabanIBA 06/2022 - 10/2013
8	fibrin fragment D (D-dimer)IBA 11/2021 - 01/2017
8	Oral ContraceptivesIBA 01/2019 - 01/2005
8	Factor VIII (Coagulation Factor VIII)IBA 10/2010 - 10/2002
7	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2022 - 12/2013
7	AntithrombinsIBA 11/2011 - 09/2007
7	Protein SIBA 11/2011 - 03/2005
6	Hemostatics (Antihemorrhagics)IBA 06/2022 - 01/2005
6	apixabanIBA 06/2022 - 11/2016
6	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
6	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 10/2013
6	Fondaparinux (Arixtra)FDA Link 12/2018 - 05/2008
5	PRT064445IBA 06/2022 - 01/2016
5	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2016
4	Ad26COVS1IBA 01/2022 - 01/2021
4	Thrombin FDA Link 01/2022 - 06/2014
4	COVID-19 VaccinesIBA 01/2022 - 01/2021
4	ORALIT (ORS)IBA 12/2021 - 10/2017
4	Dabigatran FDA Link 03/2021 - 10/2014
3	VaccinesIBA 10/2022 - 08/2021
3	Estrogens (Estrogen)FDA Link 01/2022 - 01/2005
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2011
3	Hemoglobins (Hemoglobin)IBA 12/2021 - 10/2015
3	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 08/2018
3	AntibodiesIBA 01/2021 - 09/2017
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2016
3	A-factor (Streptomyces)IBA 01/2019 - 08/2011
3	Hormones (Hormone)IBA 01/2019 - 01/2009
3	vinyltriethoxysilane (VTES)IBA 12/2018 - 02/2014
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 10/2002
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 10/2018
2	AntidotesIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2021
2	Cytochrome P-450 CYP3AIBA 01/2022 - 10/2018
2	mRNA VaccinesIBA 01/2022 - 11/2021
2	Contraceptive Agents (Contraceptives)IBA 01/2022 - 05/2014
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2021 - 02/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 10/2013
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 01/2019
2	Clopidogrel (Plavix)FDA Link 12/2017 - 01/2011

Therapy/Procedure

36	Therapeutics 01/2022 - 12/2004
5	Duration of Therapy 11/2018 - 08/2012
3	Drug Therapy (Chemotherapy) 12/2021 - 12/2014
3	Compression Stockings 11/2018 - 09/2016
2	Anticoagulation Reversal 06/2022 - 01/2021
2	Polypharmacy 01/2022 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 03/2021